MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1155/2013/926060

Медицинская библиотека · BioMed research international · 2013

Synthesis of a novel thiazolidinedione and evaluation of its modulatory effect on IFN- γ , IL-6, IL-17A, and IL-22 production in PBMCs from rheumatoid arthritis patients.

da Rocha Junior Laurindo Ferreira, Rêgo Moacyr Jesus Barreto de Melo, Cavalcanti Mariana Brayner, Pereira Michelly Cristiny, Pitta Marina Galdino da Rocha, de Oliveira Priscilla Stela Santana, Gonçalves Sayonara Maria Calado, Duarte Angela Luzia Branco Pinto, de Lima Maria do Carmo Alves, Pitta Ivan da Rocha, Pitta Maira Galdino da Rocha

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Rheumatoid arthritis (RA) is an autoimmune disease frequently characterized by chronic synovitis of multiple joints. The pathogenesis of RA is complex and involves many proinflammatory cytokines as Th17 related ones. PPAR γ is a nuclear receptor activator that represses proinflammatory gene expression. Thus, this work aimed to synthetize a new thiazolidinedione (TZD) analogue based on a well-known anti-inflammatory and PPAR γ agonist activity of this ring and evaluate its anti-inflammatory activity. After chemical structure confirmation, the compound named 5-(5-bromo-2-methoxy-benzylidene)-3-(2-nitro-benzyl)-thiazolidine-2,4-dione TM17 was submitted to cytokine releasing inhibition and PPAR γ genetic modulation assays. The new compound showed no toxicity on human and murine cells, decreasing IL-6 secretion by murine splenocytes and reducing IL-17A, IL-22, and IFN- γ expression in peripheral blood mononuclear cells from patients with RA. TM17 was more efficient in modulating the mRNA expression of PPAR γ than its well-used TZD agonist rosiglitazone. Surprisingly, TM17 was efficient on IL-17A and IFN- γ reduction, like the positive control methylprednisolone, and presented a better effect on IL-22 levels. In conclusion, PBMCs obtained from RA patients under TM17 treatment present a significant reduction in IL-17A, IL-22, and IFN- γ levels, but not IL-6 when compared with nontreated cells, as well as increase PPAR γ mRNA expression in absence of stimulus addressing it as a promising molecule in RA treatment.

Для цитирования: da Rocha Junior Laurindo Ferreira, Rêgo Moacyr Jesus Barreto de Melo, Cavalcanti Mariana Brayner, Pereira Michelly Cristiny, Pitta Marina Galdino da Rocha, de Oliveira Priscilla Stela Santana, Gonçalves Sayonara Maria Calado, Duarte Angela Luzia Branco Pinto, de Lima Maria do Carmo Alves, Pitta Ivan da Rocha, Pitta Maira Galdino da Rocha. Synthesis of a novel thiazolidinedione and evaluation of its modulatory effect on IFN- γ , IL-6, IL-17A, and IL-22 production in PBMCs from rheumatoid arthritis patients.. BioMed research international. 2013. DOI: 10.1155/2013/926060.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.